Interventional Radiology Products Market
Report ID: SQMIG35A3192
Report ID: SQMIG35A3192
sales@skyquestt.com
USA +1 351-333-4748
Report ID:
SQMIG35A3192 |
Region:
Global |
Published Date: February, 2026
Pages:
179
|Tables:
155
|Figures:
70
Global Interventional Radiology Products Market size was valued at USD 18.2 Billion in 2024 and is poised to grow from USD 19.49 Billion in 2025 to USD 33.74 Billion by 2033, growing at a CAGR of 7.1% during the forecast period (2026-2033).
The factors such as increasing rates of chronic disease, aging population and a global move from traditional surgery methods to allow for less invasive therapy options has resulted in interventional radiology products market growth, created through utilization of advanced imaging techniques (such as CT, MRI) and development of new products.
Continued advancement of products related to guide wires, catheterization systems, stent technology, embolization products, imaging techniques, and robotic systems allows for improved accuracy and speed of procedure resolution. The growth of hybrid operating rooms and access to live imaging during the procedure increases the number of hospitals, diagnostic centres, outpatient facilities, and clinics that perform these types of interventions.
The benefits associated with performing image-guided procedures, including decreased risk of infection, decreased lengths of inpatient stay and improved outcomes, are the driving factors for the movement toward erosion of the traditional surgical approach to treatment.
How will AI-driven Tools Redefine the Future of Interventional Procedures and Clinician Decision-making?
An increasing number of companies that manufacture interventional radiology (IR) products are benefiting from advancements in artificial intelligence (AI) to help them improve diagnostic accuracy, improve their efficiency in performing procedures, and obtain better results after performing procedures. These technological advances are accomplished through the use of intelligent image analysis and three-dimensional (3D) navigation tools. By having systems that use AI to assist clinicians to develop and implement a wide variety of complex procedures, clinicians are able to perform procedures with much greater confidence and with reduced risk of errors.
In 2024, several leading manufacturers introduced imaging platforms integrated with artificial intelligence (AI) capabilities to enhance procedural guidance, improve image quality, and support clinical decision-making during interventional procedures. AI-enabled tools are primarily being adopted in advanced hospitals and hybrid operating rooms, where they assist with image optimization, workflow efficiency, and procedural planning rather than fully automating clinical tasks.
Market snapshot - 2026-2033
Global Market Size
USD 29.89 Billion
Largest Segment
Stents
Fastest Growth
Vascular Closure Devices
Growth Rate
6.0% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global Interventional Radiology Products Market is segmented by Product Type, Procedure, Application and region. Based on Product Type, the market is segmented into Stents, Catheters, Filters, Thrombectomy Systems, Embolization Devices, Biopsy Needles, Accessories and Other Interventional Products. Based on Procedure, the market is segmented into Angiography, Angioplasty, Biopsy & Drainage, Embolization, Thrombolysis and Other Procedures. Based on Application, the market is segmented into Cardiology, Urology & Nephrology, Oncology, Gastroenterology, Neurology, Orthopedics and Other Applications. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
The interventional radiology products market outlook is primarily composed of stents which encompass most of the overall product revenue and demand because they are commonly used to treat cardiovascular diseases and peripheral arterial disease for the thousands of procedures performed through angioplasty areas around the world. The dominant stent product types would include new product types such as drug-eluting and bioresorbable stents, which further establish the dominant position of this segment.
As per the interventional radiology products market forecast, the fastest-growing product type within the market is vascular closure of devices. These devices have been specifically developed to close puncture wounds in blood vessels following the completion of cardiac catheterization procedures, which minimize the risk of excessive bleeding and allow for a quicker transition from hemostasis to patient reestablishment to regular activity. The increased growth and use of vascular closure devices are primarily attributed to the increasing number of non-invasive technique options available today.
As per the interventional radiology products market analysis, the angiography segment dominates the market. This is primarily due to the role angiography plays in aiding in diagnosing and treating vascular and cardiovascular diseases. Angiography helps with visualization of blood vessels and assists with several minimally invasive procedures; thus, it is considered an essential core procedure in many clinical environments.
As per the interventional radiology products industry, the embolization segment is the fastest growing in the market. The increased use of this procedure is attributed to increased use in the treatment of tumors, uterine fibroids, and vascular malformations. The expanding demand is also due to a growing market for less invasive oncology products. Ablation procedures, such as radiofrequency ablation and microwave ablation, are expanding at a healthy rate and represent an alternative treatment option that provides a viable, effective method of treating a variety of chronic conditions, especially those related to oncology and pain management.
To get detailed segments analysis, Request a Free Sample Report
As per interventional radiology products market regional outlook, North America is the top geographical region when it comes to the amount of interventional radiology products sold in the market, due to the area's technology-friendly health care systems, high volume of interventional procedures performed and early acceptance of advanced imaging and hybrid techniques for procedures. In addition, the region is highly affected by the prevalence of cardiovascular disease, peripheral arterial disease, and the catastrophic rise in the incidence of oncological patients requiring minimally invasive intervention procedures.
North America is dominated by the United States; this is the largest contributor to North America's interventional radiology products market. The high adoption of angiography, stents, embolization, and ablation devices is a result of the advanced health care infrastructure, a large number of insurances that cover procedures and availability of government-funded health care initiatives. Hospitals continue to invest in creating and maintaining Hybrid operating suites and in utilizing Artificially Intelligent Navigational Assistance to provide more accurate and efficient interventional procedures.
Growth of Canada's interventional radiology products market regional forecast is attributed to the increasing number of modernized outpatients, interventional outpatient health care centres and interventional cardiology departments in the country. Additionally, catheter-based interventional procedures and embolization procedures have become common forms of treatment for certain patients with heart disease or cancer who require highly invasive intervention.
As per interventional radiology products industry analysis, the Asia-Pacific region has experienced rapid growth over the last few years due to increasing healthcare spending, availability of larger groups of patients, and growing awareness of minimally invasive therapies. Hospitals are increasingly incorporating embolization, ablation, stent, and catheter devices in their procedures across many tumour types.
Japan has been at the forefront of adopting these advanced technologies. In addition to embracing advanced imaging technologies and utilizing AI-assisted navigation, robotic-assisted technologies, and hybrid imaging technologies are a long-term opportunity for oncological and vascular interventions.
South Korea has seen rapid growth in investment in stents, catheters, and hybrid imaging technologies. The growth of minimally invasive procedures for cardiac and oncology patients, and the development of supportive technologies from both the private sector and the government have supported this rapid growth.
The healthcare system, regulatory frameworks, and level of clinical awareness is well-established in Europe, leading to a large interventional radiology products market share. The increase in the aging population and higher incidence of cardiovascular disease and oncological diseases are factors driving this growth. As a result, hospitals in Europe are deploying stents and embolization devices as well as hybrid imaging systems (requiring all three types of devices together) to improve efficiency during procedures and shorten recovery times.
As per the interventional radiology products market regional analysis, the UK ranks first in Europe in the adoption of both angiography and stents, as well as embolization devices and all and most other types of procedures using ablation technology. Hospitals are investing in hybrid operating suites and AI systems to support imaging for improving both accuracy and clinical outcomes. Major device manufacturers and an abundance of qualified professionals to support the industry are helping contribute to the growth of this market segment.
The United Kingdom is benefitting from the government's National Health Service (NHS) initiatives as well as expanding the use of private healthcare. Thus, more stents, catheters, and embolization devices will be used for treating cardiac disease and related procedures. The continuing expansion of regulatory approvals for these products and improving the supporting reimbursement improves the ability to implement new types of devices.
France's growth is spurred on using public hospitals and private clinics focusing their specialties on embolization and ablation procedures for the oncology treatment and vascular treatment population. The French government is providing previous funding to hospitals for purchasing new invasive technology and developing policies that support their purchasing of minimally invasive technologies through financing.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Growing Preference for Minimally Invasive Procedures
Technological Advancements Fueling Innovation
High Cost of Interventional Radiology Equipment and Procedures
Limited Availability of Trained Interventional Radiology Professionals
Request Free Customization of this report to help us to meet your business objectives.
The interventional radiology products industry is relatively consolidated, with both globally known manufacturers of medical devices and newer innovative companies represented in the marketplace. Long-established companies such as Medtronic, Boston Scientific, Abbott, Becton Dickinson, Cardinal Health, B. Braun Melsungen, Terumo, Cook Medical, Siemens Healthineers, and Philips have formed a competitive ecology wherein they compete with one another by expanding their product offerings, introducing new technology into their products, and entering into partnerships that deal with hybrid imaging technologies and artificial intelligence-supported procedure platforms.
There is also a trend in the market of new companies, referred to as start-ups, being created that are developing solution sets using modern technology to reshape how imaging is done and how procedures are performed.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the demand for minimally invasive surgeries is a key driver in this market because this type of surgical procedure has many advantages over traditional surgical procedures, such as less scarring, lower complication rates, and shorter hospital stays. As patients and doctors continue to prefer minimally invasive surgeries, the use of interventional radiology products will continue to grow on a global scale. Additionally, a primary restraint on the interventional radiology products market revenue is the high cost of advanced interventional technologies and limited access in low-income areas where healthcare infrastructure and insurance are not adequately developed. As a result, the adoption of ad
vanced interventional devices has been slow. Another emerging trend is the combination of different imaging and navigation systems using hybrid technology, such as CT, MRI, and angiography, to allow surgeons to visually see on a 3-D scale at the point of surgery, improving the accuracy of surgical procedures. Regionally, the North American region has a dominant position in the interventional radiology products industry trends, due to its sophisticated and highly developed healthcare system, along with its early adoption of technology.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 18.2 Billion |
| Market size value in 2033 | USD 33.74 Billion |
| Growth Rate | 7.1% |
| Base year | 2024 |
| Forecast period | 2026-2033 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Interventional Radiology Products Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Interventional Radiology Products Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Interventional Radiology Products Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Interventional Radiology Products Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Interventional Radiology Products Market size was valued at USD 29.89 Billion in 2025 and is poised to grow from USD 31.69 Billion in 2026 to USD 47.64 Billion by 2033, growing at a CAGR of 6.0% during the forecast period (2026-2033).
The interventional radiology products industry is relatively consolidated, with both globally known manufacturers of medical devices and newer innovative companies represented in the marketplace. Long-established companies such as Medtronic, Boston Scientific, Abbott, Becton Dickinson, Cardinal Health, B. Braun Melsungen, Terumo, Cook Medical, Siemens Healthineers, and Philips have formed a competitive ecology wherein they compete with one another by expanding their product offerings, introducing new technology into their products, and entering into partnerships that deal with hybrid imaging technologies and artificial intelligence-supported procedure platforms. 'Medtronic', 'Boston Scientific Corporation', 'Abbott Laboratories', 'Becton, Dickinson and Company (BD)', 'Cardinal Health', 'B. Braun Melsungen AG', 'Terumo Corporation', 'Cook Medical', 'Siemens Healthineers AG', 'Koninklijke Philips N.V.', 'Stryker Corporation', 'Penumbra, Inc.'
One of the best-selling points of minimally invasive techniques is that they lower patient trauma, reduce risk of infection, and speed up recovery time. As the medical field moves towards an increased reliance on minimally invasive therapies, will be placed on the use of image-guided interventional techniques (IGIT) in other areas, such as oncology, cardiology (cardiac), and vascular disease treatment.
Integration of Advanced Imaging and AI-enabled Technology: A significant interventional radiology products market trends affecting the industry is the increased incorporation of Artificial Intelligence (AI) and Advanced Imaging Technologies within the traditional workflow of interventional radiologists. AI facilitated image identification/ interpretation, automated measurements, and real-time guidance during procedures to improve accuracy, decrease procedure time, and enhance clinical results. With these benefits, many hospitals and specialty centers are using smart and data-driven interventional solutions more rapidly than ever.
How Are North America and Emerging Regions Shaping Market Stability and Future Growth?
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
